Endovascular treatment of femoro-popliteal obstructive disease

Minerva Cardioangiologica

Volumn 55, Issue 1, 2007, Pages 125-132

  Rigatelli, G ^a,b   Cardaioli, P ^a   Giordan, M ^a  

^a ROVIGO GENERAL HOSPITAL   (Italy)

^b NONE   (Italy)

Author keywords

Angioplasty; Atherosclerosis; Diseases, peripheral vascular; Interventional cardiology; Stents

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DACRON; HEPARIN; POLITEF;

ATHEROSCLEROSIS; BRACHYTHERAPY; EMBOLECTOMY; FEMORAL ARTERY; FEMOROPOPLITEAL BYPASS; HUMAN; ISCHEMIA; LASER ANGIOPLASTY; LEG ISCHEMIA; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; RECANALIZATION; REVASCULARIZATION; REVIEW; STENT; THROMBECTOMY;

ANGIOPLASTY, BALLOON; ANGIOPLASTY, BALLOON, LASER-ASSISTED; ARTERIAL OCCLUSIVE DISEASES; ATHERECTOMY; CRYOTHERAPY; FEMORAL ARTERY; HUMANS; POPLITEAL ARTERY; STENTS; THROMBECTOMY; TREATMENT OUTCOME;

EID: 33947576361     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Hunik MG, Wong JB, Donaldson MC, Meyerovitz MF, de Vries J, Harrington DP. Revascularization for femoropopliteal disease: a decision and cost-effectiveness analysis. JAMA 1995;274:165-71.
2. Yeager RA, Moneta GL, Taylor LM Jr, Hamre DW, McConnell DB, Porter JM. Surgical management of severe acute lower extremity ischemia. J Vasc Surg 1992;15:385-93.
3. Nasr MK, McCarthy RJ, Budd JS, Horrocks M. Infrainguinal bypass graft patency and limb salvage rates in critical limb ischemia: influence of mode of presentation. Ann Vasc Surg 2003;17:1992-7.
4. Faries PL, LoGerfo FW, Arora S, Hook S, Pulling MC, Akbari CM et al. A comparative study of alternative conduits for lower extremity revascularization: all-autogenous conduit versus prosthetic grafts. J Vasc Surg 2000;32:1080-90.
5. Zannetti S, L'Italien GJ, Cambria RP. Functional outcome after surgical treatment for intermittent claudication. J Vasc Surg 1996;24:65-73.
6. Jamsen TS, Manninen HI, Tulla HE, Jaakkola PA, Matsi PJ. Infrainguinal revascularization because of claudication: total long-term outcome of endovascular and surgical treatment. J Vasc Surg 2003;37:808-15.
7. Goshima KR, Mills JL, Hughes JD. A new look at outcomes after infrainguinal bypass surgery: traditional reporting standards systematically underestimate the expenditure of effort required to attain limb salvage. J Vasc Surg 2004;39:330-5.
8. Schepers A, Klinkert P, Peeters V, Breslau PJ. Complication registration in patients after peripheral arterial bypass surgery. Ann Vasc Surg 2003;17:198-202.
9. L'Italien GJ, Cambria RP, Cutler BS, Leppo JA, Paul SD, Brewster DC et al. Comparative early and late cardiac morbidity among patients requiring different vascular surgery procedures. J Vasc Surg 1995;21:935-44.
10. Gibbons G, Burgess AM, Guadagnoli E, Pomposelli FB, Freeman DV, Campbell DR et al. Return to well-being and function after infrainguinal revascularization. J Vasc Surg 1995;21:35-45.
11. Zdanowski Z, Albrechtsson U, Lundin A, Jonung T, Ribbe E, Thorne J et al. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? a randomized controlled study. Int Angiol 1999;18:251-5.
12. Vroegindeweij D, Vos LD, Tielbeek AV, Buth J, vdBosch H. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study. Cardiovasc Intervent Radiol 1997;20:420-5.
13. Cejna M, Schoder M, Lammer J. [PTA vs. stent in femoropopliteal obstruction]. Radiologe 1999;39:144-50.
14. Becquemin JP, Favre JP, Marzelle J, Nemoz C, Corsin C, Leizorovicz A. Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study. J Vasc Surg 2003;37:487-94.
15. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL et al. ACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease; American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; Vascular Disease Foundation.ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113:e463-654.
16. Ouriel K, Shortell CK, DeWeese JA, Green RM, Francis CW, Azodo MV et al. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg 1994;19:1021-30.
17. Huettl EA, Soulen MC. Thrombolysis of lower extremity embolic occlusions: a study of the results of the star registry. Radiology 1995;197:141-5.
18. Matas Docampo M, Gomez Palones F, Fernandez Valenzuela V, Segarra Medrano A, Moreiras Barreiro M. Intraarterial urokinase for acute native arterial occlusion of the limbs. Ann Vasc Surg 1997;11:565-72.
19. Weaver FA, Comerota AJ, Youngblood M, Froehlicj J, Hosking JD, Papanicolaou G. Surgical revascularization versus thrombolysis for nonembolic lower extremity native arterial occlusions: results of a prospective randomized trial. The STILE Investigators. Surgery versus thrombolysis for ischemia of the lower extremity. J Vasc Surg 1996;24:513-21.
20. Korn P, Khilnani NM, Fellers JC, Lee TY, Winchester PA, Bush HL et al. Thrombolysis for native arterial occlusions of the lower extremities: clinical outcome and cost. J Vasc Surg 2001;33:1148-57.
21. Davidian MM, Powell A, Benenati JF, Katzen BT, Becker GJ, Zemel G. Initial results of reteplase in the treatment of acute lower extremity arterial occlusions. J Vasc Interv Radiol 2000;11:289-94.
22. Berczi V, Deutschmann HA, Schedlbauer P, Tauss J, Hausegger KA. Early experience and midterm follow-up results with a new rotational thrombectomy catheter. Cardiovasc Intervent Radiol 2002;25:275-81.
23. Kasirajan K, Gray B, Beavers FP, Clair DG, Greenberg R, Mascha E et al. Rheolytic thrombectomy in the management of acute and subacute limb-threatening ischemia. J Vasc Interv Radiol 200;12:413-21.
24. Cejna M, Thurnher S, Illiasch H, Horvath W, Waldenberger P, Hornik K et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol 2001;12:23-31.
25. Grimm J, Muller-Hulsbeck S, Jahnke T, Hilbert C, Brossmann J, Heller M. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol 2001;12:935-42.
26. Soder HK, Manninen HI, Rasanen HT, Kaukanen E, Jaakkola P, Matsi PJ. Failure of prolonged dilation to improve long-term patency of femoropopliteal artery angioplasty: results of a prospective trial. J Vasc Interv Radiol 2002;13:361-9.
27. Ansel GM, Botti CF Jr, George BS, Kazienko BT; IntraCoil Femoralpopliteal Stent Trial Investigators. Clinical results for the training-phase roll-in patients in the Intracoil femoralpopliteal stent trial. Catheter Cardiovasc Interv 2002;56:443-9.
28. Jahnke T, Voshage G, Muller-Hulsbeck S, Grimm J, Heller M, Brossmann J. Endovascular placement of self-expanding nitinol coil stents for the treatment of femoropopliteal obstructive disease. J Vasc Interv Radiol 2002;13:257-66.
29. Ahmadi R, Ugurluoglu A, Schillinger M, Katzenschlager R, Sabeti S, Minar E. Duplex ultrasound-guided femoropopliteal angioplasty: initial and 12-month results from a case controlled study. J Endovasc Ther 2002;9:873-81.
30. Henry M, Klonaris C, Amor M, Henry I, Tzvetanov K. State of the art: which stent for which lesion in peripheral interventions? Tex Heart Inst J 2000;27:119-26.
31. Bauermeister G. Endovascular stent-grafting in the treatment of superficial femoral artery occlusive disease. J Endovasc Ther 2001;8:315-20.
32. Deutschmann HA, Schedlbauer P, Berczi V, Portugaller H, Tauss J, Hausegger KA. Placement of Hemobahn stent-grafts in femoropopliteal arteries: early experience and midterm results in 18 patients. J Vasc Interv Radiol 2001;12:943-50.
33. Steinkamp HJ, Werk M, Haufe M, Felix R. Laser angioplasty of peripheral arteries after unsuccessful recanalization of the superficial femoral artery. Int J Cardiovasc Intervent 2000;3:153-60.
34. Michalis LK, Tsetis DK, Katsamouris AN, Rees MR, Sideris DA, Gourtsoyiannis NC. Vibrational angioplasty in the treatment of chronic femoropopliteal arterial occlusions: preliminary experience. J Endovasc Ther 2001;8:615-21.
35. Yoffe B, Yavnel L, Altshuler A, Scheinowitz M, Lebovici O. Preliminary experience with the Xtrak debulking device in the treatment of peripheral occlusions. J Endovasc Ther 2002;9:234-40.
36. Bolia A, Miles KA, Brennan J, Bell PRF. Percutaneous transluminal angioplasty of occlusions of the femoral and popliteal arteries by subintimal dissection. Cardiovasc Intervent Radiol 1990;13:357-63.
37. Laird JR. Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries. J Endovasc Ther 2006; 13 Suppl 2:II30-40.
38. Minar E, Pokrajac B, Maca T, Ahmadi R, Fellner C, Mittlbock M et al. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: results of a prospective randomized study. Circulation 2000;102:2694-9.
39. Waksman R, Laird JR, Jurkovitz CT, Lansky AJ, Gerrits F, Kosinski AS et al. Peripheral Artery Radiation Investigational Study (PARIS) Investigators. Intravascular radiation therapy after balloon angioplasty of narrowed femoropopliteal arteries to prevent restenosis: results of the PARIS feasibility clinical trial. J Vasc Interv Radiol. 2001;12:915-21.
40. Bonvini R, Baumgartner I, Do DD, Alerci M, Segatto JM, Tutta P et al. Late acute thrombotic occlusion after endovascular brachytherapy and stenting of femoropopliteal arteries. J Am Coll Cardiol 2003;41:409-12.
41. Fattori R, Piva T. Drug-eluting stents in vascular intervention. Lancet 2003;361:247-9.
42. Duda SH, Pusich B, Richter G, Landwehr P, Oliva VL, Tielbeek A et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 2002;106:1505-9.
43. Tsetis D, Belli AM. Guidelines for stenting in infrainguinal arterial disease. Cardiovasc Intervent Radiol 2004;27:198-203.
44. Jahnke T, Andresen R, Muller-Hulsbeck S, Schafer FK, Voshage G, Heller M et al. Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: mid-term results of a prospective trial. J Vasc Interv Radiol 2003;14:41-51.
45. Ahmadi R, Schillinger M, Maca T, Minar E. Femoropopliteal arteries: immediate and long-term results with a Dacron-covered stent-graft. Radiology 2002;223:345-50.